文献速递艾滋病与性传播感染

早期启动抗逆转录病毒治疗对垂直感染HIV-1儿童代谢谱的影响

Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

本研究比较了围产期感染HIV-1、接受抑制性cART的儿童中,早期启动cART(出生后12周内,n=10)与晚期启动cART(出生后12-50周,n=10)的血浆蛋白质组、脂质组和代谢组谱。结果显示,188种鉴定蛋白中有7种在两组间存在差异,脂质组(n=115)和代谢组(n=81)谱无差异,但蛋白与脂质及代谢物水平强相关,且蛋白比值对早期和晚期组有高判别力。结论提示晚期启动cART与不同的促炎状态相关,可能触发非AIDS事件。

要点

  • 早期cART组与晚期cART组的血浆蛋白质组存在差异,188种蛋白中7种不同。
  • 两组间脂质组和代谢组谱未见显著差异。
  • 蛋白与脂质及代谢物水平强相关,蛋白比值可高判别早期与晚期cART组。

核心结论

  • 晚期启动cART的围产期HIV-1感染儿童表现出不同的促炎蛋白特征,可能与未来非AIDS事件风险相关。
  • 建议围产期获得性HIV-1感染儿童尽早启动抗逆转录病毒治疗以预防远期并发症。

研究设计与样本

  • 研究纳入接受抑制性cART的围产期HIV-1感染儿童,早期cART组(出生后12周内启动,n=10)和晚期cART组(出生后12-50周启动,n=10)。
  • 采用nanoLC-Orbitrap进行血浆蛋白质组分析,UHPLC-qTOF进行脂质组分析,GC-qTOF进行代谢组分析。

主要发现

  • 在188种鉴定蛋白中,7种在早期和晚期cART组间存在差异。
  • 脂质组(n=115)和代谢组(n=81)谱在两组间无差异。
  • 蛋白质与脂质水平及代谢物(包括糖组分和氨基酸)之间发现强相关性,且与临床参数相关。
  • 不同蛋白质之间的比值对早期和晚期cART组显示出高判别力。

临床怎么用

  • 对于围产期获得性HIV-1感染儿童,应尽早启动cART以预防远期代谢及动脉粥样硬化性疾病等非AIDS并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early combined antiretroviral treatment (cART) in perinatally acquired HIV-1 children has been associated with a rapid viral suppression, small HIV-1 reservoir size and reduced mortality and morbidity. Immunometabolism has emerged as an important field in HIV-1 infection offering both relevant knowledge regarding immunopathogenesis and potential targets for therapies against HIV-1. OBJECTIVES: To characterize the proteomic, lipidomic and metabolomic profile of HIV-1-infected children depending on their age at cART initiation. PATIENTS AND METHODS: Plasma samples from perinatally HIV-1-infected children under suppressive cART who initiated an early cART (first 12 weeks after birth, EARLY, n = 10) and late cART (12-50 weeks after birth, LATE, n = 10) were analysed. Comparative plasma proteomics, lipidomics and metabolomics analyses were performed by nanoLC-Orbitrap, UHPLC-qTOF and GC-qTOF, respectively. RESULTS: Seven of the 188 proteins identified exhibited differences comparing EARLY and LATE groups of HIV-1-infected children. Despite no differences in the lipidomic (n = 115) and metabolomic (n = 81) profiles, strong correlations were found between proteins and lipid levels as well as metabolites, including glucidic components and amino acids, with clinical parameters. The ratio among different proteins showed high discriminatory power of EARLY and LATE groups. CONCLUSIONS: Protein signature show a different proinflammatory state associated with a late cART introduction. Its associations with lipid levels and the relationships found between metabolites and clinical parameters may potentially trigger premature non-AIDS events in this HIV-1 population, including atherosclerotic diseases and metabolic disorders. Antiretroviral treatment should be started as soon as possible in perinatally acquired HIV-1-infected children to prevent them from future long-life complications.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Tarancón-Diez L, Rull A, Herrero P, et al. Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children. J Antimicrob Chemother. 2021. PMID: 34463735. doi:10.1093/jac/dkab277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。